In Brief
Refine Search
Biotechnology
Boston-based biotech firm Ginkgo Bioworks has announced significant workforce reductions as part of its ongoing restructuring efforts. 28 June 2024
Pharmaceutical
BRIEF—Lexicon Pharmaceuticals resubmits sotagliflozin NDA 21 June 2024
Biotechnology
BRIEF—Cipla EU to invest an additional 3 million euros in Ethris 19 June 2024
Biotechnology
BRIEF—Efgartigimod in PC-POTS is not clinically meaningful 17 June 2024
Biosimilars
BRIEF—BI0SECURE Act left out of 2025 US Defense Bill 15 June 2024
Pharmaceutical
BRIEF—BARDA awards up to $500 million for vaccine clinical trials 15 June 2024
Pharmaceutical
BRIEF—Pfizer to ‘Catch Our Breath’ on deals after $43 billion purchase 12 June 2024
Biotechnology
BRIEF—EMA approves variation for Kite’s CAR-T cell therapies 6 June 2024
Biotechnology
BRIEF—uniQure receives FDA RMAT designation for AMT-130 in Huntington’s 3 June 2024
Pharmaceutical
BRIEF—Boehringer COPD and asthma inhalers now available for $35 a month 1 June 2024
Biotechnology
BRIEF—FDA acknowledges Astellas’ BLA resubmission for zolbetuximab 31 May 2024
Pharmaceutical
BRIEF—FDA approves Austedo XR as one pill taken once-daily 30 May 2024
Pharmaceutical
Helsinn and Angelini Pharma have renewed their distribution and licence agreement for Aulin (nimesulide) and Mesulid (nimesulide). 28 May 2024
Biotechnology
BRIEF—Alzheimer’s drug Leqembi approved in South Korea 28 May 2024
Pharmaceutical
BRIEF—Despite missed deadline, WHO pandemic treaty remains urgent 25 May 2024
Pharmaceutical
BRIEF—Russia experiencing boom in sales of antidepressants 21 May 2024
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze